April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Proteomic Analysis of Glaucomatous Retinae
Author Affiliations & Notes
  • Nils Boehm
    Experimental Ophthalmology,
    University Medical Center, Mainz, Germany
  • Sabine Beck
    Experimental Ophthalmology,
    University Medical Center, Mainz, Germany
  • Jan M. Vetter
    Experimental Ophthalmology,
    University Medical Center, Mainz, Germany
  • Norbert Pfeiffer
    Ophthalmology,
    University Medical Center, Mainz, Germany
  • Franz H. Grus
    Experimental Ophthalmology,
    University Medical Center, Mainz, Germany
  • Footnotes
    Commercial Relationships  Nils Boehm, None; Sabine Beck, None; Jan M. Vetter, None; Norbert Pfeiffer, None; Franz H. Grus, None
  • Footnotes
    Support  Deutsche Forschungsgemeinschaft (Gr1463/4-2)
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 4585. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Nils Boehm, Sabine Beck, Jan M. Vetter, Norbert Pfeiffer, Franz H. Grus; Proteomic Analysis of Glaucomatous Retinae. Invest. Ophthalmol. Vis. Sci. 2011;52(14):4585.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Recent studies reported alterations in the expression levels of some proteins in glaucomatous retinae. However, up to now mostly single proteins were analyzed, thus a broad insight into proteome alterations related to glaucomatous neurodegeneration is still missing. To address this question we performed a mass spectrometry based study, analyzing the retinae of glaucoma patients in comparison to those of healthy subjects.

Methods: : Retinae were obtained from donor eyes of 5 healthy and 5 glaucomatous donors. Retina proteins were extracted, fractionated via SDS-PAGE and digested tryptically. In the second dimension tryptic peptides were fractionated by use of C18 chromatographie. Mass spectrometry analysis was performed using a MALDI-Orbitrap-XL. Identified proteins were quantified and assignment of protein functions was carried out by Gene Ontology data base search.

Results: : The explorative protein analysis leads to the identification of 278 proteins. 44 of these were found to be significantly decreased (P≤0.01) in glaucomatous retinae, e.g. RAB1C (fold decrease: -19.1±8.5), alpha/beta-tubulin (fd: -12.6±5.6; - 15.9±4.5) or superoxide dismutase and peroxiredoxin1 (fd: -5.2±3.4; -7.8±3.2). 25 proteins were found in higher quantities, e.g. A/B-crystallin (fold increase: +6.4±4.2; +7.8±6.7) or members of the HSP family (HSP90:+10.3±8.9; HSP77: +2.9±2.2). The annotation of protein functions revealed functional groups, such as vesicular trafficking, cytoskeleton associated proteins or proteins involved into the removal of ROS to be significantly overrepresented (P≤5E-6) within the groups of differential expressed proteins.

Conclusions: : The present data disclose deep insights into processes associated with glaucomatous neurodegeneration. For example, several proteins involved into the regulation of apoptotic pathways revealed to be differentially expressed, reflecting the apoptotic events within the retinal ganglion cell layer. Proteins involved into the elemination of ROS were found to be considerably diminished in glaucomatous retinae, thus suggesting an insufficient ability of patients to counterbalance the increased level of ROS in glaucomatous retinae. All in all the generated data demonstrate that proteins involved in manifold different pathways and mechanisms are affected in context of glaucomatous neurodegeneration.

Keywords: proteomics • retina 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×